Literature DB >> 31996023

Evidence-Based Medical Management of Peripheral Artery Disease.

Graham H Bevan1,2, Khendi T White Solaru1,3,2.   

Abstract

Peripheral artery disease is an atherosclerotic disease of the lower extremities associated with high cardiovascular mortality. Management of this condition may include lifestyle modifications, medical management, endovascular repair, or surgery. The medical approach to peripheral artery disease is multifaceted and includes cholesterol reduction, antiplatelet therapy, anticoagulation, peripheral vasodilators, blood pressure management, exercise therapy, and smoking cessation. Adherence to this regimen can reduce limb-related complications like critical limb ischemia and amputation, as well as systemic complications of atherosclerosis like stroke and myocardial infarction. Relative to coronary artery disease, peripheral artery disease is an undertreated condition. In this article, we explore the evidence behind medical therapies for the management of peripheral artery disease.

Entities:  

Keywords:  atherosclerosis; blood pressure; cardiovascular disease; cholesterol; peripheral artery disease; stroke; vascular medicine

Year:  2020        PMID: 31996023     DOI: 10.1161/ATVBAHA.119.312142

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  15 in total

Review 1.  Atherosclerosis and Atrial Fibrillation: Double Trouble.

Authors:  Mehran Abolbashari
Journal:  Curr Cardiol Rep       Date:  2022-01-06       Impact factor: 2.931

Review 2.  Femoral-popliteal peripheral artery disease: From symptom presentation to management and treatment controversies.

Authors:  Anna K Krawisz; Aishwarya Raja; Eric A Secemsky
Journal:  Prog Cardiovasc Dis       Date:  2021-02-13       Impact factor: 8.194

Review 3.  Skeletal Muscle Mitochondrial Dysfunction and Oxidative Stress in Peripheral Arterial Disease: A Unifying Mechanism and Therapeutic Target.

Authors:  Kyoungrae Kim; Erik M Anderson; Salvatore T Scali; Terence E Ryan
Journal:  Antioxidants (Basel)       Date:  2020-12-18

4.  Geographic Disparities in Readmissions for Peripheral Artery Disease in South Carolina.

Authors:  Brian Witrick; Corey A Kalbaugh; Lu Shi; Rachel Mayo; Brian Hendricks
Journal:  Int J Environ Res Public Health       Date:  2021-12-28       Impact factor: 3.390

5.  Effect of Revascularization on Intramuscular Vascular Endothelial Growth Factor Levels in Peripheral Arterial Disease.

Authors:  Larissa Schawe; Ben Raude; Jan Christoph Carstens; Irene Hinterseher; Raphael Donatus Hein; Safwan Omran; Gilles Berger; Nina A Hering; Matthias Buerger; Andreas Greiner; Jan Paul Frese
Journal:  Biomedicines       Date:  2022-02-17

6.  Effects of PCSK9 Inhibitor on Favorable Limb Outcomes in Patients with Chronic Limb-Threatening Ischemia.

Authors:  Yusuke Sato; Hiroyasu Uzui; Tetsuji Morishita; Yoshitomo Fukuoka; Kanae Hasegawa; Hiroyuki Ikeda; Naoto Tama; Kentaro Ishida; Shinsuke Miyazaki; Hiroshi Tada
Journal:  J Atheroscler Thromb       Date:  2020-09-25       Impact factor: 4.928

7.  Peripheral Artery Disease as a Risk Factor for Myocardial Infarction.

Authors:  Erick Leonel Pérez Mejias; Sila Mateo Faxas; Nicole Tejeda Taveras; Abdul Subhan Talpur; Jitesh Kumar; Maria Khalid; Suraj K Aruwani; Dua Khalid; Haya Khalid; Sidra Memon
Journal:  Cureus       Date:  2021-06-15

Review 8.  Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation.

Authors:  José Miguel Rivera-Caravaca; Anny Camelo-Castillo; Inmaculada Ramírez-Macías; Pablo Gil-Pérez; Cecilia López-García; María Asunción Esteve-Pastor; Esteban Orenes-Piñero; Antonio Tello-Montoliu; Francisco Marín
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

9.  Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease.

Authors:  Martin Wawruch; Jan Murin; Tomas Tesar; Martina Paduchova; Miriam Petrova; Denisa Celovska; Beata Havelkova; Michal Trnka; Emma Aarnio
Journal:  Front Pharmacol       Date:  2021-05-19       Impact factor: 5.810

10.  Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease.

Authors:  Martin Wawruch; Jan Murin; Tomas Tesar; Martina Paduchova; Miriam Petrova; Denisa Celovska; Petra Matalova; Beata Havelkova; Michal Trnka; Emma Aarnio
Journal:  Biomedicines       Date:  2021-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.